SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-013983
Filing Date
2024-04-30
Accepted
2024-04-30 16:22:06
Documents
15
Period of Report
2024-04-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20240430_8k.htm   iXBRL 8-K 28945
2 EXHIBIT 99.1_PHASE 1 TOPLINE DATA_24-0430 ex_664492.htm EX-99.1 17550
  Complete submission text file 0001437749-24-013983.txt   184640

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240430.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240430_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240430_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240430_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240430_8k_htm.xml XML 2853
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 24897625
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)